Cyclooxygenase-derived vasoconstriction restrains hypoxia-mediated cerebral vasodilation in young adults with metabolic syndrome

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 306, Issue 2, 2014, Pages

  Harrell, John W ^a   Schrage, William G ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Cerebral blood flow; Cyclooxygenase; Metabolic syndrome

Indexed keywords

INDOMETACIN; PLACEBO; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; VASOCONSTRICTOR AGENT;

ADULT; AGING; ARTICLE; BRAIN BLOOD FLOW; BRAIN HYPOXIA; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; HYPERCAPNIA; MALE; METABOLIC SYNDROME X; OXYGEN SATURATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VASODILATATION;

CEREBRAL BLOOD FLOW; CYCLOOXYGENASE; METABOLIC SYNDROME;

ADULT; ANOXIA; BLOOD FLOW VELOCITY; CARBON DIOXIDE; CYCLOOXYGENASE INHIBITORS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERCAPNIA; INDOMETHACIN; MALE; METABOLIC SYNDROME X; MIDDLE CEREBRAL ARTERY; OXYGEN; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL; VASOCONSTRICTION; VASODILATION;

EID: 84892605970     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00709.2013     Document Type: Article

References (35)

1. Barnes JN, Schmidt JE, Nicholson WT, Joyner MJ. Cyclooxygenase inhibition abolishes age-related differences in cerebral vasodilator responses to hypercapnia. J Appl Physiol 112: 1884-1890, 2012.
2. Boden-Albala B, Sacco RL, Lee HS, Grahame-Clarke C, Rundek T, Elkind MV, Wright C, Giardina EG, DiTullio MR, Homma S, Paik MC. Metabolic syndrome and ischemic stroke risk: Northern Manhattan Study. Stroke 39: 30-35, 2008.
3. Coyle MG, Oh W, Petersson KH, Stonestreet BS. Effects of indomethacin on brain blood flow, cerebral metabolism, and sagittal sinus prostanoids after hypoxia. Am J Physiol Heart Circ Physiol 269: H1450-H1459, 1995.
4. Di Carlo A. Human and economic burden of stroke. Age Ageing 38: 4-5, 2009.
5. Erdos B, Miller AW, Busija DW. Impaired endothelium-mediated relaxation in isolated cerebral arteries from insulin-resistant rats. Am J Physiol Heart Circ Physiol 282: H2060-H2065, 2002.
6. Fan JL, Burgess KR, Thomas KN, Peebles KC, Lucas SJ, Lucas RA, Cotter JD, Ainslie PN. Influence of indomethacin on the ventilatory and cerebrovascular responsiveness to hypoxia. Eur J Appl Physiol 111: 601-610, 2011.
7. Fan JL, Burgess KR, Thomas KN, Peebles KC, Lucas SJ, Lucas RA, Cotter JD, Ainslie PN. Influence of indomethacin on ventilatory and cerebrovascular responsiveness to CO2 and breathing stability: the influence of PCO2 gradients. Am J Physiol Regul Integr Comp Physiol 298: R1648-R1658, 2010.
8. Feletou M, Cohen RA, Vanhoutte PM, Verbeuren TJ. TP receptors and oxidative stress hand in hand from endothelial dysfunction to atherosclerosis. Adv Pharmacol 60: 85-106, 2010.
9. Feletou M, Huang Y, Vanhoutte PM. Endothelium-mediated control of vascular tone: COX-1 and COX-2 products. Br J Pharmacol 164: 894-912, 2011.
10. Fredricks KT, Liu Y, Rusch NJ, Lombard JH. Role of endothelium and arterial K channels in mediating hypoxic dilation of middle cerebral arteries. Am J Physiol Heart Circ Physiol 267: H580-H586, 1994.
11. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, Montori VM. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 49: 403-414, 2007.
12. Giannopoulos S, Boden-Albala B, Choi JH, Carrera E, Doyle M, Perez T, Marshall RS. Metabolic syndrome and cerebral vasomotor reactivity. Eur J Neurol 17: 1457-1462, 2010.
13. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735-2752, 2005.
14. Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, Powers WJ, DeCarli C, Merino JG, Kalaria RN, Vinters HV, Holtzman DM, Rosenberg GA, Wallin A, Dichgans M, Marler JR, Leblanc GG. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 37: 2220-2241, 2006.
15. Harrell JW, Morgan BJ, Schrage WG. Impaired hypoxic cerebral vasodilation in younger adults with metabolic syndrome. Diab Vasc Dis Res 10: 135-142, 2013.
16. Katakam PV, Domoki F, Snipes JA, Busija AR, Jarajapu YP, Busija DW. Impaired mitochondria-dependent vasodilation in cerebral arteries of Zucker obese rats with insulin resistance. Am J Physiol Regul Integr Comp Physiol 296: R289-R298, 2009.
17. Kurl S, Laukkanen JA, Niskanen L, Laaksonen D, Sivenius J, Nyyssonen K, Salonen JT. Metabolic syndrome and the risk of stroke in middle-aged men. Stroke 37: 806-811, 2006.
18. Limberg JK, Harrell JW, Johansson R, Eldridge MW, Proctor LT, Sebranek JJ, Schrage WG. Microvascular function in younger adults with obesity and metabolic syndrome: role of oxidative stress. Am J Physiol Heart Circ Physiol 305: H1230-H1237, 2013.
19. Marshall RS, Rundek T, Sproule DM, Fitzsimmons BF, Schwartz S, Lazar RM. Monitoring of cerebral vasodilatory capacity with transcranial Doppler carbon dioxide inhalation in patients with severe carotid artery disease. Stroke 34: 945-949, 2003.
20. McSwain SD, Hamel DS, Smith PB, Gentile MA, Srinivasan S, Meliones JN, Cheifetz IM. End-tidal and arterial carbon dioxide measurements correlate across all levels of physiologic dead space. Respir Care 55: 288-293, 2010.
21. Panza F, Frisardi V, Capurso C, Imbimbo BP, Vendemiale G, Santamato A, D'Onofrio G, Seripa D, Sancarlo D, Pilotto A, Solfrizzi V. Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms. J Alzheimers Dis 21: 691-724, 2010.
22. Phillips SA, Sylvester FA, Frisbee JC. Oxidant stress and constrictor reactivity impair cerebral artery dilation in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 288: R522-R530, 2005.
23. Poulin MJ, Robbins PA. Indexes of flow and cross-sectional area of the middle cerebral artery using Doppler ultrasound during hypoxia and hypercapnia in humans. Stroke 27: 2244-2250, 1996.
24. Reichmuth KJ, Dopp JM, Barczi SR, Skatrud JB, Wojdyla P, Hayes D Jr, Morgan BJ. Impaired vascular regulation in patients with obstructive sleep apnea: effects of continuous positive airway pressure treatment. Am J Respir Crit Care Med 180: 1143-1150, 2009.
25. Rodriguez-Colon SM, Mo J, Duan Y, Liu J, Caulfield JE, Jin X, Liao D. Metabolic syndrome clusters and the risk of incident stroke: the atherosclerosis risk in communities (ARIC) study. Stroke 40: 200-205, 2009.
26. Silvestrini M, Vernieri F, Pasqualetti P, Matteis M, Passarelli F, Troisi E, Caltagirone C. Impaired cerebral vasoreactivity and risk of stroke in patients with asymptomatic carotid artery stenosis. JAMA 283: 2122-2127, 2000.
27. Taddei S, Virdis A, Mattei P, Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 21: 929-933, 1993.
28. Tomiyama Y, Brian JE Jr, Todd MM. Cerebral blood flow during hemodilution and hypoxia in rats: role of ATP-sensitive potassium channels. Stroke 30: 1942-1947; discussion 1947-1948, 1999.
29. Van Guilder GP, Hoetzer GL, Greiner JJ, Stauffer BL, Desouza CA. Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults. Obesity (Silver Spring) 14: 2127-2131, 2006.
30. Vieira JR, Elkind MS, Moon YP, Rundek T, Boden-Albala B, Paik MC, Sacco RL, Wright CB. The metabolic syndrome and cognitive performance: the Northern Manhattan Study. Neuroepidemiology 37: 153-159, 2011.
31. Wannamethee SG, Shaper AG, Lennon L, Morris RW. Metabolic syndrome vs. Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 165: 2644-2650, 2005.
32. Willie CK, Macleod DB, Shaw AD, Smith KJ, Tzeng YC, Eves ND, Ikeda K, Graham J, Lewis NC, Day TA, Ainslie PN. Regional brain blood flow in man during acute changes in arterial blood gases. J Physiol 590: 3261-3275, 2012.
33. Wilson MH, Edsell ME, Davagnanam I, Hirani SP, Martin DS, Levett DZ, Thornton JS, Golay X, Strycharczuk L, Newman SP, Montgomery HE, Grocott MP, Imray CH. Cerebral artery dilatation maintains cerebral oxygenation at extreme altitude and in acute hypoxia-an ultrasound and MRI study. J Cereb Blood Flow Metab 31: 2019-2029, 2011.
34. Xie A, Skatrud JB, Barczi SR, Reichmuth K, Morgan BJ, Mont S, Dempsey JA. Influence of cerebral blood flow on breathing stability. J Appl Physiol 106: 850-856, 2009.
35. Xie A, Skatrud JB, Morgan B, Chenuel B, Khayat R, Reichmuth K, Lin J, Dempsey JA. Influence of cerebrovascular function on the hypercapnic ventilatory response in healthy humans. J Physiol 577: 319-329, 2006.